MktsMarkets

Bioventus Inc.
NASDAQ: BVSKey statistics
BVS News
Stories mentioning BVS from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 28 | Q4 '25Dec 31 | Q3 '25Sep 27 | Q2 '25Jun 28 | Q1 '25Mar 29 | Q4 '24Dec 31 | Q3 '24Sep 28 | Q2 '24Jun 29 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 132,089 | 157,900 | 138,651 | 147,660 | 123,876 | 153,642 | 138,964 | 151,217 |
| Cost of Goods Sold | 41,320 | 49,118 | 44,422 | 45,570 | 40,820 | 50,986 | 45,413 | 47,578 |
| Gross Profit | 90,769 | 108,782 | 94,229 | 102,090 | 83,056 | 102,656 | 93,551 | 103,639 |
| Operating Expenses | ||||||||
| Research & Development | 2,467 | 3,007 | 2,923 | 3,172 | 3,011 | 3,271 | 3,843 | 4,210 |
| Sales General & Admin | 78,325 | 82,757 | 78,657 | 79,110 | 73,502 | 86,873 | 81,482 | 96,668 |
| Total Operating Expenses | ||||||||
| Operating Income (Loss) | 8,416 | 19,486 | 11,252 | 18,368 | 4,869 | 7,703 | 3,647 | (31,473) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | 427.00 | (37.00) | (79.00) | (561.00) | (777.00) | 1,241 | 626.00 | (159.00) |
| Pretax Income | 4,517 | 14,143 | 4,670 | 10,313 | (3,417) | (53.00) | (5,259) | (41,556) |
| Tax Provision | 571.00 | (3,175) | 664.00 | 1,041 | (95.00) | 550.00 | 589.00 | (7,339) |
| Net Income (Loss) | 3,113 | 14,755 | 3,155 | 7,459 | (2,637) | (388.00) | (5,165) | (25,682) |
| Earnings Per Share (Basic) | 0.05 | 0.22 | 0.05 | 0.11 | (0.04) | (0.01) | (0.08) | (0.40) |
| Earnings Per Share (Diluted) | 0.04 | 0.21 | 0.05 | 0.11 | (0.04) | (0.01) | (0.08) | (0.40) |
| Weighted Average Shares Outstanding (Basic) | 67,296 | 66,623 | 66,925 | 66,500 | 66,009 | 64,547 | 65,258 | 64,057 |
| Weighted Average Shares Outstanding (Diluted) | 70,008 | 68,915 | 68,838 | 68,537 | 66,009 | 64,547 | 65,258 | 64,057 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About BVS
Bioventus Inc. (NASDAQ: BVS) is a stock listed on the Nasdaq Stock Market under the ticker symbol BVS. It last traded at $10.86 (Nov 12, 2026, 4:00 PM ET), down 1.2% on the day. That gives Bioventus a market capitalisation of $926.0M and a price-to-earnings ratio of 17.0.
Over the past 52 weeks BVS has traded between $6.47 and $15.89.
Revenue for the quarter ended Mar 28, 2026 was $132.1M; net income $3.1M. Revenue was up 6.6% from $123.9M in the quarter ended Mar 29, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 28, 2026 | $132.1M | $3.1M | 2.4% |
| Dec 31, 2025 | $157.9M | $14.8M | 9.3% |
| Sep 27, 2025 | $138.7M | $3.2M | 2.3% |
| Jun 28, 2025 | $147.7M | $7.5M | 5.1% |
From Bioventus’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…